Shay Turpin joins WRBL News3 Midday to speak about Ovarian and Breast Cancer Awareness and an event that hopes to show ...

An alarming number of women are unaware of the tell-tale signs of a deadly cancer that kills thousands each year, new ...

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of ...

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

In May, the FDA granted significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

One of the strongest risk factors for breast cancer is inherited genetic mutations, especially in the BRCA1 and BRCA2 genes.

Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.

Jay Harris, who has anchored for SportsCenter for over 10 years has shared he has been diagnosed with prostate cancer and ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...